Aspire Pharma has launched Eysano 2.5mg/ml and 5mg/ml eye drops (timolol), a new preservative-free product indicated in ocular hypertension, chronic open-angle glaucoma including aphakic patients, and in some adult patients with secondary glaucoma.

Eysano is the first in a new range of preservative-free ophthalmic medications from Aspire Pharma to be marketed under the ‘ey’ brand.

Aspire’s managing director, Graham Fraser-Pye, said: “We are delighted to be launching the first multidose preservative-free version of timolol to the UK market.”

Tel: 01730 231148